Abstract:Early detection of high-risk individuals is crucial for healthcare systems to cope with changing demographics and an ever-increasing patient population. Images of the retinal fundus are a non-invasive, low-cost examination routinely collected and potentially scalable beyond ophthalmology. Prior work demonstrated the potential of retinal images for risk assessment for common cardiometabolic diseases, but it remains unclear whether this potential extends to a broader range of human diseases. Here, we extended a retinal foundation model (RETFound) to systematically explore the predictive potential of retinal images as a low-cost screening strategy for disease onset across >750 incident diseases in >60,000 individuals. For more than a third (n=308) of the diseases, we demonstrated improved discriminative performance compared to readily available patient characteristics. This included 281 diseases outside of ophthalmology, such as type 2 diabetes (Delta C-Index: UK Biobank +0.073 (0.068, 0.079)) or chronic obstructive pulmonary disease (Delta C-Index: UK Biobank +0.047 (0.039, 0.054)), showcasing the potential of retinal images to complement screening strategies more widely. Moreover, we externally validated these findings in 7,248 individuals from the EPIC-Norfolk Eye Study. Notably, retinal information did not improve the prediction for the onset of cardiovascular diseases compared to established primary prevention scores, demonstrating the need for rigorous benchmarking and disease-agnostic efforts to design cost-efficient screening strategies to improve population health. We demonstrated that predictive improvements were attributable to retinal vascularisation patterns and less obvious features, such as eye colour or lens morphology, by extracting image attributions from risk models and performing genome-wide association studies, respectively. Genetic findings further highlighted commonalities between eye-derived risk estimates and complex disorders, including novel loci, such as , for iron homeostasis. In conclusion, we present the first comprehensive evaluation of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of easily accessible and low-cost retinal images for risk assessment across common and rare diseases.

Standardization and clinical applications of retinal imaging biomarkers for cardiovascular disease: a Roadmap from an NHLBI workshop

Retinal imaging in Alzheimer's and neurodegenerative diseases

Optical Coherence Tomography Angiography Biomarkers as Indicators of Cardiovascular Disease

Oculomics: A Crusade Against the Four Horsemen of Chronic Disease

Retinal Imaging-Based Oculomics: Artificial Intelligence as a Tool in the Diagnosis of Cardiovascular and Metabolic Diseases

The New Era of Retinal Imaging in Hypertensive Patients

Advances in retinal imaging biomarkers for the diagnosis of cerebrovascular disease

Imaging the eye as a window to brain health: frontier approaches and future directions

Retina Oculomics in Neurodegenerative Disease

Retinal Fractal Dimension Is a Potential Biomarker for Systemic Health—Evidence From a Mixed-Age, Primary-Care Population

A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre

Retinal biomarkers in vascular occlusion

Retinal imaging for the assessment of stroke risk: a systematic review

A predictive atlas of disease onset from retinal fundus photographs

AI-integrated ocular imaging for predicting cardiovascular disease: advancements and future outlook

Abstract 10113: Validation of a Deep-Learning-Based Retinal Biomarker in the Prediction of Cardiovascular Disease: Data From UK Biobank

Advances in Structural and Functional Retinal Imaging and Biomarkers for Early Detection of Diabetic Retinopathy

Predicting Cardiovascular Risk Factors from Retinal Fundus Photographs using Deep Learning

Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank

Computational Retinal Microvascular Biomarkers from an OCTA Image in Clinical Investigation

Noninvasive Retinal Markers in Diabetic Retinopathy: Advancing from Bench towards Bedside